Neuropsychiatry of Huntington's disease and other basal ganglia disorders

Psychosomatics

Volumn 41, Issue 1, 2000, Pages 24-30

  Rosenblatt, Adam ^a   Leroi, Iracema ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIANDROGEN; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; LEUPRORELIN; LITHIUM; NEFAZODONE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; VALPROATE SEMISODIUM; VENLAFAXINE;

AGGRESSION; APATHY; ARTICLE; DELIRIUM; DEMENTIA; DEPRESSION; DYSKINESIA; EXTRAPYRAMIDAL SYNDROME; FAHR DISEASE; HUMAN; HUNTINGTON CHOREA; IRRITABILITY; MANIA; MENTAL DISEASE; OBSESSION; PARKINSONISM; PHENOMENOLOGY; PREVALENCE; PSYCHOSIS; SEXUAL DYSFUNCTION; WILSON DISEASE;

EID: 0033959889     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-3182(00)71170-4     Document Type: Article

References (47)

1. Huntington G: On chorea. Medical and Surgical Reports of Philadelphia 1872; 26:317-321
2. McHugh PR: The neuropsychiatry of basal ganglia disorders: a triadic syndrome and its explanation. Neuropsychiatry Neuropsychol Behav Neurol 1989; 2:239-247
3. Ross ED, Rush JA: Diagnosis and neuroanatomical correlates of depression brain-damaged patients: implications for a neurology of depression. Arch Gen Psychiatry 1981; 38:1344-1354
4. Folstein SE, Chase G, Wahl W, et al: Huntington's disease in Maryland: clinical aspects of racial variation. Am J Hum Genet 1987; 41:168-179
5. Folstein SE: Huntington's Disease: A Disorder of Families. Baltimore, MD, Johns Hopkins University Press, 1989
6. Shoenfield M, Myers RH, Cupples RA, et al: Increased rate of suicide among patients with Huntington's disease. J Neurol Neurosurg Psychiatry 1984; 47:1283-1287
7. Vonsattel JP, Meyers RH, Stevens TJ, et al: Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 1985; 44:559-577
8. Alexander GE, DeLong MR, Strick PL: Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Ann Rev Neurosci 1986; 9:357-381
9. Cummings JL: Frontal-subcortical circuits and human behavior. Arch Neurol 1993; 50:873-880
10. Mayberg HS, Starkstein SE, Peyser CE, et al: Paralimbic frontal lobe hypometabolism in depression associated with Huntington's disease. Neurology 1992; 42:1791-1797
11. Baxter LR, Mazziotta JC, Pahl JJ, et al: Psychiatric, genetic, and positron emission tomographic evaluation of persons at risk for Huntington's disease. Arch Gen Psychiatry 1992; 49:148-152
12. Denning TR, Berrios GE: Wilson's disease: psychiatric symptoms of 195 cases. Arch Gen Psychiatry 1989; 46:1126-1134
13. Schneider LS, Chui HC: Progressive supranuclear palsy manifesting with depressive features. J Am Geriatric Soc 1986; 34:663-665
14. Ranen NG, Peyser CE, Folstien SE: ECT as a treatment for depression in Huntington's disease. J Neuropsychiatry 1994; 6:154-158
15. Figiel GS, Krishna KR, Doraiswamy PM: Subcortical structural change in ECT-induced delirium. J Geriatr Psychiatry Neurol 1990; 3:172-176
16. Mendez MF: Huntington's disease: update and review of neuropsychiatric aspects. Int J Psychiatry Med 1994; 24:189-208
17. Litvan I, Mega MS, Cummings JL, et al: Neuropsychiatric aspects of progressive supranuclear palsy. Neurology 1996; 47:1184-1189
18. Lyketsos CG, Schwartz J, Fishman M, et al: AIDS mania. J Neuropsychiatry Clin Neurosci 1997; 9:277-279
19. Pantelis C, Barnes TRE, Nelson HE: Is the concept of frontalsubcortical dementia relevant to schizophrenia? Br J Psychiatry 1992; 160:442-460
20. Caligiuri MP, Lohr JB, Jeste DV: Parkinsonism in neuroleptic-naïve schizophrenic patients. Am J Psychiatry 1993; 150:1343-1348
21. Bolt JMW: Huntington's chorea in the west of Scotland. Br J Psychiatry 1970; 116:259-270
22. Morris M: Psychiatric aspects of Huntington's disease, in Huntington's Disease: Major Problems in Neurology. Edited by Harper PS. London, UK, Saunders, 1991, pp 81-126
23. Brooks DS, Murphy MP, Janota I, et al: Early onset Huntington's chorea: diagnostic clues. Br J Psychiatry 1987; 151:850-852
24. Cummings JL: Behavioral and psychiatric symptoms associated with HD, in Advances in Neurology, Vol 65. Edited by Weiner WJ, Lang AE. New York, Raven, 1995, pp 179-186
25. Kuwert T, Lange HW, Langen K-J, et al: Cerebral glucose consumption measured by PET in patients with and without psychiatric symptoms of Huntington's disease. Psychiatr Res 1989; 29:361-362
26. Cummings JL: Psychosis in basal ganglia disorders, in Mental Dysfunction in Parkinson's Disease. Edited by Welters Ech, Scheltens P. Amsterdam, The Netherlands, Vrije Universiteit Amsterdam, 1993, pp 257-268
27. Scheinberg I, Sternlieb I: Wilson's Disease. Philadelphia, PA, WB Saunders, 1984, pp 86-91
28. Lishman A: Organic Psychiatry: The Psychological Consequences of Cerebral Disorder, 3rd Edition. Oxford, UK, Blackwell Science Ltd, 1998, pp 349-356
29. Von Eonomo C: Encephalitis lethargica: its sequelae and treatment. (First published in 1929.) Translated by Newman KO. Oxford, UK, Oxford University Press, 1931
30. Davison K, Bagley CR: Schizophrenia-like psychoses associated with organic disorders of the central nervous system: a review of the literature, in Current Problems in Neuropsychiatry, edited by Herrington RN. Br J Psychiatry Special Publication, No. 4. London, UK, Ashford, Kent, Headley Brothers, 1969
31. Cummings JL, Gosenfeld LF, Holihan JP, et al: Neuropsychiatric disturbances associated with idiopathic calcification of the basal ganglia. Biol Psychiatry 1983; 18:591-601
32. Flint J, Goldstein LH: Familial calcification of the basal ganglia: a case report and review of the literature. Psychol Med 1992; 22:581-595
33. Evans DL, Pedersen CA, Tancer ME: ECT in the treatment of organic psychosis in Huntington's disease. Convuls Ther 1987; 3:145-150
34. Hurwitz TA, Calne DB, Waterman K: Treatment of dopaminomimetic psychosis in Parkinson's disease with electroconvulsive therapy. Can J Neurol Sci 1988; 15:32-34
35. Cummings JL, Cunningham K: Obsessive-compulsive disorders in Huntington's disease. Biol Psychiatry 1992; 31:263-270
36. Kurlan R: Tourette's syndrome: current concepts. Neurology 1989; 39:1625-1630
37. Dewhurst K, Oliver JE, McKnight AL: Socio-psychiatric consequences of Huntington's disease. Br J Psychiatry 1970; 116:255-258
38. Burns A, Folstein S, Brandt J, et al: Clinical assessment of irritability, aggression, and apathy in Huntington's disease and Alzheimer's disease. J Nerv Ment Dis 1990; 178-206
39. Rosenblatt A, Ranen N, Nance MA, et al: A Physician's Guide to the Management of Huntington's Disease, 2nd Edition. New York, Huntington's Disease Society of America, 1999
40. Stewart JT, Mounts ML, Clark RL: Aggressive behavior in Huntington's disease: treatment with propanolol. J Clin Psychiatry 1987; 48:106-108
41. Stewart JT: Huntington's disease and proponolol. Am J Psychiatry 1993; 150:166-167
42. Stewart JT: Paradoxical aggressive effect of propanolol in a patient with Huntington's disease (letter). J Clin Psychiatry 1987; 48:25-26
43. Greendyke RM, Kanter DR: Therapeutic effects of pindolol on behavioral disturbances associated with organic brain disease: a double-blind study. J Clin Psychiatry 1986; 47:423-426
44. Van Hafften AH, Jensen CF: Paradoxical response to pindolol treatment for aggression in a patient with Huntington's disease (letter). J Clin Psychiatry 1989; 50:230
45. Caine ED, Shoulson I: Psychiatric syndromes in Huntington's disease. Am J Psychiatry 1983; 140:728-733
46. Fedoroff JP, Peyser C, Franz ML, et al: Sexual disorders in Huntington's disease. J Neuropsychiatry Clin Neurosci 1994; 6:147-153
47. Oliver JE: Huntington's chorea in Northamptonshire. Br J Psychiatry 1970; 116:241-253